A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) ...

The Christie NHS Foundation Trust together with the Cancer Research UK National Biomarker Centre and The University of ...

We're talking with Dr. Richard Miller, founder of Bay Dermatology, at their Downtown St. Pete location to discuss Mohs ...

The idea that a prolonged interval between diagnosing and treating uveal melanoma can affect prognosis has been at the centre of an active debate.1–5 This issue focuses on a key question for ...

A new study led by researchers at Lund University in Sweden reveals that melanoma can, in some cases, be driven by ...

Institut Curie researchers have identified a sex-specific molecular pathway connecting E-cadherin loss, estrogen receptor-α ...

While melanoma primarily affects people with fair skin, it can affect anyone, according to plastic surgeon, Dr. Srikanth ...

Researchers studied the progression-free and overall survival rates of patients with advanced melanoma after cessation of immune checkpoint inhibitor therapy.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Like other cancers, melanoma is rising among young adults. It's now the 2nd most common cancer in 15 to 39 year-olds.

The thickness of the melanoma also guides the choice of treatment. Another system describes the thickness of a melanoma in relation to its penetration into the skin instead of actually measuring it.

EXCLUSIVE: Skin cancers can be among the most aggressive forms of the disease so using drugs to shrink them must be used with precision.